Table of contents
I. Investment Summary ...................................................................................................
II. Valuation......................................................................................................................
III. Healthcare, pharma to grow faster than other sectors...........................................
1. Aging population
2. Increase in per-capita medical spending
IV. Structural changes in pharmaceutical industry ......................................................
1. Domestic pharmaceutical market
2. Pharmaceutical market in US and emerging countries
[Company Analysis]
Hanmi Pharm (008930.KS, Buy, TP W144,000) ...........................................................
LGLS (068870.KS, Buy, TP W90,000) ...........................................................................
Daewoong Pharm (069620.KS, Buy, TP W72,000) ......................................................
Dong-A Pharm (000640.KS, Buy, TP W130,000) ..........................................................
Yuhan (000100.KS, HOLD, TP W200,000) ....................................................................
Green Cross (006280.KS, HOLD, TP W150,000) .........................................................
3
5
10
14
19
25
31
35
40
45